Back
Entrada Therapeutics Stock Predictions
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
41
TRDA
Entrada Therapeutics
Last Price:
13.68
Seasonality Move:
13.84%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Entrada Therapeutics Stock Forecast
- Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 0.5% based on the past 2 years of stock performance.
- Entrada Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Entrada Therapeutics Stock Undervalued?
The current Entrada Therapeutics [TRDA] share price is $14.16. The Score for TRDA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. - TRDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Entrada Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 0.5% based on the past 2 years of stock performance.
Entrada Therapeutics Stock Rating
Sell
41
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics overpriced?
- Entrada Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Entrada Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com
52-Week Data
52-Week High:
18.17
52-Week Low:
10.75
Prediction Charts
Market Cap:
526.75M
Price in USD:
14.16
Volume:
160.01K
Beta:
-0.23
Technical Analysis
SMA50:
16.00
SMA100:
15.32
SMA200:
14.67
52-Wk Change:
-14.85%
Stock Predictions
-
Is Entrada Therapeutics stock public?
Yes, Entrada Therapeutics is a publicly traded company. -
What is the Entrada Therapeutics stock quote today?
The Entrada Therapeutics stock price is 14.16 USD today. -
How to buy Entrada Therapeutics stock online?
You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-28 | 16.60 | 16.32 | 16.85 | 16.14 |
| Aug-29 | 16.50 | 17.50 | 17.59 | 16.39 |
| Aug-30 | 17.72 | 17.70 | 17.85 | 17.08 |
| Sep-3 | 17.66 | 15.64 | 17.75 | 15.44 |
| Sep-4 | 15.87 | 15.40 | 15.87 | 15.04 |
| Sep-5 | 15.38 | 15.39 | 15.58 | 14.99 |
| Sep-6 | 15.32 | 14.78 | 15.63 | 14.62 |
| Sep-9 | 14.75 | 15.03 | 15.33 | 14.70 |
| Sep-10 | 15.01 | 14.72 | 15.05 | 14.58 |
| Sep-11 | 14.72 | 14.86 | 15.03 | 14.54 |
| Sep-12 | 14.98 | 14.85 | 15.23 | 14.67 |
| Sep-13 | 15.12 | 15.00 | 15.19 | 14.94 |
| Sep-16 | 15.06 | 14.55 | 15.42 | 14.50 |
| Sep-17 | 14.55 | 14.16 | 14.58 | 13.90 |
Entrada Therapeutics Earnings
Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Entrada Therapeutics Forecast Revenue Growth
Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.